» Articles » PMID: 17021176

Bidirectional Trafficking of Prostaglandin E2 Receptors Involved in Long-term Potentiation in Visual Cortex

Overview
Journal J Neurosci
Specialty Neurology
Date 2006 Oct 6
PMID 17021176
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Although prostaglandin E2 (PGE2) has a broad spectrum of biological activities that have been confirmed by previous studies, the roles of PGE2 in synaptic plasticity such as long-term potentiation (LTP) in the CNS have yet to be characterized in detail. The present results of electrophysiological and biochemical studies indicated that PGE2 is actually produced in acute visual cortex slices in response to theta-burst stimulation (TBS) and is involved postsynaptically in TBS-induced LTP. RNA interference (RNAi) for PGE2 receptor subtypes EP2 and EP3, which are known to upregulate and downregulate the level of cAMP, respectively, induced significant decreases and increases of LTP, respectively. Moreover, analysis of the localization of receptor subtypes at the membrane surface or cytosol showed that stimuli such as TBS regulate the trafficking of EP2 and EP3 between the membrane and cytosol of the postsynapses, rising up to and leaving the membrane, respectively, resulting in increased and decreased expression of EP2 and EP3 at the membrane, respectively. Increased activation of EP2 and decreased activation of EP3 by PGE2 synergistically induce an increase in cAMP level, which may induce LTP. This causes activation of CREB (cAMP response element-binding protein) in the postsynaptic cells, which may be involved in the maintenance of LTP. These observations indicate that in TBS-induced LTP of the visual cortex, PGE2 is released from the postsynaptic cells and then activates PGE2 receptors at the postsynaptic membranes, which is regulated by trafficking of the differential PGE2 receptor subtypes in an activity-dependent bidirectional manner.

Citing Articles

Targeting memory loss with aspirin, a molecular mechanism perspective for future therapeutic approaches.

Gholami M, Sadegh M, Koroush-Arami M, Norouzi S, Arismani R, Asadi E Inflammopharmacology. 2023; 31(6):2827-2842.

PMID: 37924473 DOI: 10.1007/s10787-023-01347-1.


Immune-Triggered Forms of Plasticity Across Brain Regions.

Hikosaka M, Kawano T, Wada Y, Maeda T, Sakurai T, Ohtsuki G Front Cell Neurosci. 2022; 16:925493.

PMID: 35978857 PMC: 9376917. DOI: 10.3389/fncel.2022.925493.


Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation.

Jiang C, Caskurlu A, Ganesh T, Dingledine R Brain Behav Immun Health. 2021; 8:100132.

PMID: 34589882 PMC: 8474496. DOI: 10.1016/j.bbih.2020.100132.


Dissection method affects electrophysiological properties of hippocampal slices.

Stein L, Zorumski C, Izumi Y Oruen. 2018; 3(2):94-101.

PMID: 30556063 PMC: 6292686.


PGE2-EP3 signaling exacerbates hippocampus-dependent cognitive impairment after laparotomy by reducing expression levels of hippocampal synaptic plasticity-related proteins in aged mice.

Xiao J, Xiong B, Zhang W, Zhou W, Yang H, Gao F CNS Neurosci Ther. 2018; 24(10):917-929.

PMID: 29488342 PMC: 6490074. DOI: 10.1111/cns.12832.


References
1.
Christoforidis S, McBride H, Burgoyne R, Zerial M . The Rab5 effector EEA1 is a core component of endosome docking. Nature. 1999; 397(6720):621-5. DOI: 10.1038/17618. View

2.
Zhang J, Rivest S . Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur J Neurosci. 1999; 11(8):2651-68. DOI: 10.1046/j.1460-9568.1999.00682.x. View

3.
Malenka R, Nicoll R . Long-term potentiation--a decade of progress?. Science. 1999; 285(5435):1870-4. DOI: 10.1126/science.285.5435.1870. View

4.
Narumiya S, Sugimoto Y, Ushikubi F . Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999; 79(4):1193-226. DOI: 10.1152/physrev.1999.79.4.1193. View

5.
Jovanovic J, Czernik A, Fienberg A, Greengard P, Sihra T . Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci. 2000; 3(4):323-9. DOI: 10.1038/73888. View